Cadila Healthcare to develop vaccines for ‘Congo Virus’ and ‘Ebola Virus’

31 Dec 2014 Evaluate

Cadila Healthcare is developing vaccines for ‘Congo Virus’ and ‘Ebola Virus’ as a part of Company's vaccine development programme. However, the company has not shared investment details.

Cadila Healthcare operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.

Zydus Lifesciences Share Price

909.55 8.25 (0.92%)
31-Dec-2025 11:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1267.00
Cipla 1498.65
Zydus Lifesciences 909.55
Lupin 2091.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×